AG&P Pratham Kicks-Off Construction of Its Second Liquefied and Compressed Natural Gas (LCNG) Station in Andhra Pradesh
KADAPA, India--(BUSINESS WIRE)--AG&P Pratham in India, the City Gas Distribution (CGD) arm of Singapore-based AG&P…
4 years ago
Vingroup and VinFast successfully raised the first international green syndicated loan
December 22, 2021, Vingroup successfully closed the first international sustainable syndicated loan transaction of $400…
4 years ago
Razer Merchant Services, the First Merchant Acquirer to Enable DuitNow QR, Cross-Border QR & Online Banking/Wallets for Merchants
Razer Merchant Services is the first Merchant Acquirer to enable PayNet’s Real-Time Retail Payments Platform…
4 years ago
Back to School with Dad encourages fathers to be more involved in their children’s schooling journey
SINGAPORE - Media OutReach - 28 December 2021 - Fathers from over 120 pre-schools, primary…
4 years ago
Global Science City Dialogue Highlights Role of Science Cities in Fostering International Innovation and Collaboration
AMSTERDAM--(BUSINESS WIRE)--#CSTB--Representatives from science and technology parks around the world took part in the Global…
4 years ago
The First Vanity Fair NFT cover soon in auction on APENFT’s marketplace
SINGAPORE - Media OutReach - 28 December 2021 - APENFT Foundation partners with Valuart to…
4 years ago
RoboSense Receives BYD’s Strategic Investment and Becomes an Engaged Participant of the Auto Industry
Upgraded partnership to accelerate the global mass production and implementation of smart vehicles SHENZHEN, China--(BUSINESS…
4 years ago
QX Augments Senior Leadership Team
Appoints Sagar Ahuja as Director and to the Board with the additional responsibility to lead…
4 years ago
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy
First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination KENILWORTH, N.J. & TOKYO--(BUSINESS WIRE)--$MRK…
4 years ago
ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area
Grand Pharma has licensed the development, manufacturing and commercialization rights of ITM’s Targeted Radionuclide Therapeutic…
4 years ago